Syncom Formulations Gains 8.18%: 3 Key Technical and Fundamental Factors Driving the Move

4 hours ago
share
Share Via
Syncom Formulations (India) Ltd delivered a strong weekly gain of 8.18%, closing at Rs.16.14 on 21 August 2026, significantly outperforming the Sensex which declined by 0.40% over the same period. The stock’s performance was shaped by a mix of technical developments, including a Golden Cross formation and shifting momentum indicators, alongside contrasting fundamental signals highlighted by a recent downgrade to Sell by MarketsMojo. This review analyses the key events and price movements that defined Syncom’s week.

Key Events This Week

17 Aug: Stock opens at Rs.15.21, up 1.94% despite Sensex decline

18 Aug: Downgrade to Sell rating announced amid mixed signals

19 Aug: Golden Cross formation signals potential bullish breakout

20 Aug: Technical momentum shifts to mildly bullish despite price dip

21 Aug: Stock surges 4.26% on heavy volume, closing at Rs.16.14

Week Open
Rs.15.21
Week Close
Rs.16.14
+8.18%
Week High
Rs.16.14
vs Sensex
+8.58%

17 August 2026: Positive Start Amid Market Weakness

Syncom Formulations began the week on a positive note, closing at Rs.15.21, a 1.94% gain from the previous Friday’s close of Rs.14.92. This outperformance was notable as the Sensex declined by 0.15% to 36,907.46. The stock’s volume was robust at 561,694 shares, indicating early buying interest despite broader market weakness. This initial strength set the tone for the week’s technical developments.

18 August 2026: Downgrade to Sell Amid Mixed Financial and Technical Signals

On 18 August, Syncom was downgraded from a 'Hold' to a 'Sell' rating by MarketsMOJO, reflecting concerns over its long-term growth prospects despite recent positive quarterly earnings. The stock closed at Rs.15.57, up 2.37% on the day, even as the Sensex fell 0.43% to 36,749.23. The downgrade was driven by a deteriorating technical outlook, subdued valuation appeal, and disappointing five-year sales decline of -53.39% annually. However, short-term profitability remained strong with a half-year PAT of ₹50.02 crores and ROCE of 24.55%. The mixed signals contributed to cautious investor sentiment despite the price rise.

19 August 2026: Golden Cross Formation Signals Potential Bullish Breakout

On 19 August, Syncom formed a Golden Cross, where the 50-day moving average crossed above the 200-day moving average, a classic bullish technical indicator. This event suggested a potential shift in momentum towards sustained upward movement. Despite this, the stock price retreated 1.41% to Rs.15.35 amid a broader market decline of 0.47%. The Golden Cross was supported by bullish daily moving averages and weekly MACD, though monthly indicators remained bearish, signalling a cautious outlook for longer-term investors.

Transformation in full progress! This Micro Cap from Auto Ancillary just achieved sustainable profitability after tough times. Be early to witness this powerful comeback story!

  • - Sustainable profitability reached
  • - Post-turnaround strength
  • - Comeback story unfolding

Be Early to the Comeback →

20 August 2026: Technical Momentum Shifts to Mildly Bullish Despite Price Dip

On 20 August, Syncom’s stock price dipped 2.50% to Rs.15.18 on relatively low volume of 246,651 shares. Despite this decline, technical momentum indicators shifted from mildly bearish to mildly bullish. Daily moving averages turned bullish, and weekly MACD supported positive momentum. However, monthly MACD and KST oscillators remained bearish, indicating longer-term caution. The Relative Strength Index (RSI) was neutral, and Bollinger Bands showed bullish weekly but mildly bearish monthly signals. This mixed technical landscape suggested a tentative recovery phase amid ongoing volatility.

21 August 2026: Strong Rally on Heavy Volume Closes Week at Rs.16.14

The week concluded with a strong rally on 21 August, as Syncom surged 4.26% to close at Rs.16.14, its weekly high, on heavy volume of 1,139,452 shares. This sharp gain outpaced the Sensex’s marginal 0.02% rise to 36,814.22. The surge followed the prior day’s technical momentum shift and was supported by the Golden Cross formation. The stock’s micro-cap status and recent downgrade to Sell contrasted with this bullish price action, reflecting a complex interplay of short-term optimism and longer-term caution among investors.

Date Stock Price Day Change Sensex Day Change
2026-08-17 Rs.15.21 +1.94% 36,907.46 -0.15%
2026-08-18 Rs.15.57 +2.37% 36,749.23 -0.43%
2026-08-19 Rs.15.35 -1.41% 36,577.15 -0.47%
2026-08-20 Rs.15.48 +0.85% 36,808.42 +0.63%
2026-08-21 Rs.16.14 +4.26% 36,814.22 +0.02%

Key Takeaways

Positive Signals: Syncom’s 8.18% weekly gain significantly outperformed the Sensex’s 0.40% decline, driven by a Golden Cross formation and a shift to mildly bullish technical momentum on daily and weekly charts. The stock’s recent half-year PAT growth of 49.75% and strong ROCE of 24.55% underpin operational strength. The surge on 21 August on heavy volume suggests renewed buying interest.

Cautionary Factors: Despite short-term technical optimism, the downgrade to Sell by MarketsMOJO highlights concerns over long-term sales decline (-53.39% annualised over five years) and subdued institutional interest. Monthly momentum indicators remain bearish, and the stock’s micro-cap status entails higher volatility and risk. The mixed technical signals advise prudence for longer-term investors.

Holding Syncom Formulations (India) Ltd from ? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!

  • - Peer comparison ready
  • - Superior options identified
  • - Cross market-cap analysis

Switch to Better Options →

Conclusion

Syncom Formulations experienced a volatile but ultimately positive week, with an 8.18% gain that outpaced the broader market. The formation of a Golden Cross and a shift to mildly bullish technical momentum on shorter timeframes signal potential for further near-term gains. However, the recent downgrade to Sell by MarketsMOJO, driven by long-term sales decline and mixed technical indicators, tempers enthusiasm and underscores the need for caution. Investors should weigh the company’s operational profitability and historical outperformance against the risks posed by its micro-cap status and subdued institutional interest. The stock remains at a technical and fundamental crossroads, warranting close monitoring of upcoming price action and market developments.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News